Life Sciences Virtual Investor Conference: Company Executives Present Live September 16th

Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.

Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET on Thursday, September 16 th with the first live webcast at 9:30 AM ET.

REGISTER NOW AT: https://bit.ly/3zZKJoC

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend the live presentations or ask questions.

"We are delighted to host today's innovators from the life science sector," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "Our Virtual Investor Conference platform continues to provide a unique opportunity for these companies to communicate their strategies to a broader investor base."

Agenda and presenting companies:

Time (ET) Presenting Company Ticker(s)
9:30 AM VolitionRx Limited NYSE AMERICAN: VNRX
10:00 AM Avicanna Inc. ( OTCQX: AVCNF | TSX: AVCN)
10:30 AM Alpha Cognition Inc. OTCQB: ACOGF | TSX-V: ACOG
11:00 AM Willow Biosciences Inc. ( OTCQB: CANSF | TSX: WLLW)
11:30 AM Filament Health Corp. ( Pink: FLHLF | NEO: FH)
12:00 PM Novamind Inc. ( OTCQB: NVMDF | CSE: NM)
12:30 PM Salarius Pharmaceuticals, Inc. Nasdaq: SLRX
1:00 PM MedX Health Corp. TSX-V: MDX
1:30 PM Wesana Health Holdings Inc. ( OTCQB: WSNAF | CSE: WESA)
2:00 PM Compass Therapeutics, Inc. OTCQB: CMPX
2:30 PM Else Nutrition Holdings Inc. ( OTCQX: BABYF | TSX-V: BABY)

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com .

About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.


CONTACT Life Sciences Investor Forum John M. Viglotti SVP Corporate Services, Investor Access (212) 220-2221 johnv@lifesciencesinvestorforum.com

Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)
avicanna news

Avicanna

Leading Biopharmaceutical Research and Development of Commercialized Cannabinoid-Based Products for Global Markets

Leading Biopharmaceutical Research and Development of Commercialized Cannabinoid-Based Products for Global Markets Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...
Cannabis leaf on road marked with "2025," with sunlight in the background.

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025

Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve. Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among... Keep Reading...

Latest Press Releases

Related News